Want to see HK:8372 full AI Analyst Report?
Grand Brilliance Group Holdings Limited (8372) AI Stock Analysis
Grand Brilliance Group Holdings Limited
(HKEX:8372)
The stock is supported by strong financial performance and a solid valuation, with a reasonable P/E ratio and dividend yield. However, technical indicators suggest caution due to overbought conditions. The lack of earnings call and corporate events data limits further insights.
Grand Brilliance Group Holdings Limited (8372) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 132.80M
- Dividend Yield
- 1.51%
- Average Volume (3M)
- 308.86K
- Price to Earnings (P/E)
- 12.6
- Beta (1Y)
- 0.20
- Revenue Growth
- 6.63%
- EPS Growth
- -11.02%
- Country
- Hong Kong
- Employees
- 51
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Distribution
Grand Brilliance Group Holdings Limited Business Overview & Revenue Model
Company Description
Grand Brilliance Group Holdings Limited, an investment holding entity, primarily operates by distributing medical equipment and related items across Hong Kong. Its extensive product portfolio encompasses various medical supplies, including disposable...
How the Company Makes Money
null
Grand Brilliance Group Holdings Limited Financial Statement Overview
Summary
Grand Brilliance Group Holdings Limited demonstrates strong revenue growth and profitability, supported by a robust balance sheet with low leverage. However, the significant decline in free cash flow growth and low operating cash flow coverage ratio highlight potential cash flow management challenges.
Income Statement
75PositiveBalance Sheet
80PositiveCash Flow
60Neutral| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.98M | 100.71M | 94.45M | 81.90M | 76.70M | 71.98M |
| Gross Profit | 46.60M | 43.80M | 45.72M | 41.94M | 39.51M | 36.35M |
| EBITDA | 10.31M | 9.34M | 13.95M | 13.20M | 14.09M | 9.87M |
| Net Income | 9.24M | 8.41M | 9.46M | 7.86M | 7.56M | 4.05M |
Balance Sheet | ||||||
| Total Assets | 134.70M | 134.70M | 132.19M | 114.50M | 115.25M | 110.32M |
| Cash, Cash Equivalents and Short-Term Investments | 57.41M | 54.19M | 60.96M | 60.47M | 61.86M | 55.74M |
| Total Debt | 2.05M | 2.05M | 3.91M | 1.43M | 4.45M | 4.48M |
| Total Liabilities | 17.15M | 17.15M | 20.75M | 11.22M | 16.58M | 16.82M |
| Stockholders Equity | 117.20M | 117.20M | 110.79M | 103.33M | 98.67M | 93.51M |
Cash Flow | ||||||
| Free Cash Flow | -6.51M | 0 | 1.17M | 4.91M | 12.60M | -4.12M |
| Operating Cash Flow | -5.34M | 0 | 1.35M | 6.72M | 12.66M | -3.33M |
| Investing Cash Flow | 2.50M | 0 | 3.77M | -395.00K | -510.00K | -3.96M |
| Financing Cash Flow | -5.76M | 0 | -4.87M | -7.42M | -6.40M | -7.58M |
Grand Brilliance Group Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8372, the sentiment is Positive. The current price of 0.17 is below the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.16, and above the 200-day MA of 0.14, indicating a bullish trend. The MACD of 0.00 indicates Positive momentum. The RSI at 62.35 is Neutral, neither overbought nor oversold. The STOCH value of 68.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8372.
Grand Brilliance Group Holdings Limited Peers Comparison
Overall Rating
HK:219281Outperform- HK:837268.1Neutral
HK:228947Neutral
HK:067337Underperform
HK:193126Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2192 | 81Outperform | HKD 4.67B | 11.63 | 7.05% | 4.98% | 6.47% | 8.10% |
| HK:8372 | 68Neutral | HKD 132.80M | 12.57 | 9.21% | 1.51% | 6.63% | -11.02% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:2289 | 47Neutral | HKD 592.92M | 10.83 | 7.70% | 6.26% | 14.25% | 0.83% |
| HK:0673 | 37Underperform | HKD 360.66M | -5.29 | -273.18% | ― | 5.52% | 56.54% |
| HK:1931 | 26Underperform | HKD 575.63M | -6.46 | -2.60% | ― | -2.55% | -145.60% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:8372 | Grand Brilliance Group Holdings Limited | 0.17 | 0.07 | 69.39% | |
| HK:0673 | China Health Group | 0.26 | -0.36 | -58.06% | |
| HK:1931 | IVD Medical Holding Limited | 0.35 | -5.93 | -94.35% | |
| HK:2192 | Medlive Technology Co., Ltd. | 6.30 | -4.03 | -38.99% | |
| HK:2289 | Charmacy Pharmaceutical Co., Ltd. Class H | 5.49 | 0.38 | 7.46% | |
| HK:2427 | Guanze Medical Information Industry (Holding) Co., Ltd. | 2.30 | 1.80 | 360.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Dec 09, 2025